Australia TGA ARTG recordDermatological extracorporeal shock wave therapy system
Australia TGA ARTG Registered Device · Elogio Asia Aust Pty Ltd · W-Medical · Class IIa · Started December 04, 2017
Good Name: Elogio Asia Aust Pty Ltd - Dermatological extracorporeal shock wave therapy system
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- December 04, 2017
- Effective Date
- December 04, 2017
- Name
- W-Medical
- Country
- South Korea
- Address
- 601, 6F 339 Sunhwagung-ro Namyangju-si, Gyeonggi-do
The device is designed to provide extracorporeal shock wave therapy (ESWT) intended to treat acute and chronic conditions of the skin and subcutaneous soft tissues (e.g., arterial, venous, cellulite)
Access comprehensive regulatory information for Dermatological extracorporeal shock wave therapy system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Elogio Asia Aust Pty Ltd, manufactured by W-Medical in South Korea. The device registration started on December 04, 2017.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.